Epidemiology of eyelid disorders in an elderly population: Tehran Geriatric Eye Study - Report - MDSpire

Epidemiology of eyelid disorders in an elderly population: Tehran Geriatric Eye Study

  • By

  • Hassan Hashemi

  • Alireza Mohammadi

  • Mohamadreza Aghamirsalim

  • Alireza Hashemi

  • Mehdi Khabazkhoob

  • June 25, 2026

  • 0 min

Share

Prevalence of Eyelid Disorders Among Older Adults: Findings from the Tehran Geriatric Eye Study

Overview

The Tehran Geriatric Eye Study reveals a significant prevalence of eyelid disorders among older adults, with 41% affected.

Background

Eyelid disorders are common in the elderly. Understanding the prevalence of these disorders is essential for guiding healthcare resources.

Data Highlights

The study utilized a cross-sectional design to assess the prevalence of eyelid disorders among participants aged 60 years and older in Tehran.

Key Findings

  • 41% of individuals over 50 years of age are affected by eyelid disorders.
  • Age-related changes in eyelid structure can lead to conditions such as dermatochalasis, ptosis, ectropion, and entropion.
  • The prevalence of malignant eyelid tumors increases with age, particularly basal cell carcinoma and squamous cell carcinoma.
  • Geographical disparities exist in the reported prevalence of eyelid disorders among the elderly.

Clinical Implications

Healthcare professionals should consider eyelid disorders in their clinical assessments.

Conclusion

The findings from the Tehran Geriatric Eye Study highlight the prevalence of eyelid disorders in the aging population.

Related Resources & Content

  1. Lin et al., 2018 -- Prevalence of Eyelid Disorders
  2. American Academy of Ophthalmology, 2024 -- Blepharitis Preferred Practice Pattern
  3. FDA, 2023 -- Drug Trials Snapshots: XDEMVY
  4. Optometric Management — Identifying MGD in Young Patients
  5. Contact Lens Spectrum — Ocular and Refractive Considerations for the Aging Eye
  6. conexiant — Side Effects: Context Is the Diagnosis
  7. Ocular and Refractive Considerations for the Aging Eye
  8. Identifying MGD in Young Patients
  9. Blepharitis Preferred Practice Pattern® - Ophthalmology
  10. Drug Trials Snapshots: XDEMVY | FDA

Original Source(s)

Epidemiology of eyelid disorders in an elderly population: Tehran Geriatric Eye Study

  • by Hassan Hashemi, Alireza Mohammadi, Mohamadreza Aghamirsalim, Alireza Hashemi, Mehdi Khabazkhoob

  • June 25, 2026

Related Content

Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery

IL-6 Inhibitor Vamikibart Shows Efficacy Signals in DME Trial

At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.

Lutein Supplementation May Improve Outcomes in Early AMD

Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease